Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding and a Royalty Pharma option for an additional $425 million, to support Teva’s anti-IL-15 candidate, ...

Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding and a Royalty Pharma option for an additional $425 ...

CellVoyant, an AI-first biotech based in Bristol UK,  today launches FateView™, the first online predictive cell analytics platform designed to help cell-based therapeutic drug developers reduce costs ...

The city is turning its full attention to the unhoused community next week while also providing a tasty opportunity to assist ...

Horizon Recovery Confirms Ongoing Clinical Operations for Teen Rehabs in Arizona BUCKEYE, AZ, UNITED STATES, January 7, ...

Stakeholders in youth development, digital innovation and agriculture have called for stronger collaboration, ethical ...

Summit School District last spring grappled with an uptick in the use of racially charged language and a rise in reported ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

MISSISSAUGA, ON / ACCESS Newswire / January 9, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF) (Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it has updated ...

The Mecosta Conservation District is currently taking orders for their 2026 annual tree and shrub sales and native plant ...